We are live on
!
Find out more
JC
JBF Capital Portfolio holdings
AUM
$764M
Turnover
38.35%
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
+0.07%
1 Year Est. Return
+24.26%
3 Year Est. Return
+93.63%
5 Year Est. Return
+127.41%
10 Year Est. Return
+469.69%
AUM
$633M
AUM Growth
-$163M
(-20%)
Cap. Flow
-$171M
Cap. Flow
% of AUM
-27.07%
Top 10 Holdings %
Top 10 Hldgs %
87.77%
Holding
108
New
44
Increased
9
Reduced
4
Closed
26
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
1.7
years
Top 20 Avg Time Held Equity + Options
1.2
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$6.93M |
| 2 |
GE Aerospace
GE
|
+$6.18M |
| 3 |
ACTA
Actua Corp
ACTA
|
+$5.71M |
| 4 |
Kearny Financial
KRNY
|
+$4.73M |
| 5 |
Chord Energy
CHRD
|
+$4.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$223M |
| 2 |
SRUN
Silver Run Acquisition Corporation II Class A
SRUN
|
+$9.46M |
| 3 |
AABA
Altaba Inc
AABA
|
+$4.19M |
| 4 |
QIWI
QIWI PLC
QIWI
|
+$869K |
| 5 |
HTM
U.S. Geothermal Inc.
HTM
|
+$236K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.26% |
| 2 | Financials | 6.68% |
| 3 | Technology | 4.79% |
| 4 | Consumer Discretionary | 3.24% |
| 5 | Healthcare | 2.75% |
Similar funds
UCMOK
EIM
CAAM
KLI
CT
ANRF
NI
HI
JBF Capital's Q1 2018 Portfolio in Review
As of Q1 2018, JBF Capital held 108 positions worth $633M, down 20% from $795M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
JBF Capital withdrew a net $171M in Q1 2018, closing 26 positions and reducing 4 holdings. Its most notable exit was Silver Run Acquisition Corporation II Class A, an estimated $9.46M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 87% a quarter earlier, followed by Financials and Technology.
Against the trend, JBF Capital opened a new position in Alexion Pharmaceuticals worth $6.46M.
- JBF Capital's largest Q1 2018 buy was Alexion Pharmaceuticals: 58,000 shares worth $6.46M.
- JBF Capital added most to Chord Energy in Q1 2018, an estimated $4.49M increase.
- JBF Capital's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
- JBF Capital fully exited Silver Run Acquisition Corporation II Class A in Q1 2018, selling an estimated $9.46M.
- JBF Capital's ten largest holdings make up 88% of its $633M portfolio in Q1 2018.
- JBF Capital opened 44 new positions and closed 26 in Q1 2018.
- JBF Capital's portfolio value fell 20% quarter-over-quarter to $633M.
Based on JBF Capital's 13F filing for Q1 2018, filed 11 May 2018.